^
    CANCER:

    Thymus Cancer





    Show legend
    Group by Gene:
    Include preclinical:

    0
    Bifunctional alkylating agent
    ifosfamide
    1
    Topoisomerase II inhibitor, DNA inhibitor
    etoposide oral
    2
    Tubulin polymerization promoter
    carboplatin
    3
    DNA synthesis inhibitor
    gemcitabine
    4
    mTOR inhibitor
    everolimus
    5
    Topoisomerase II inhibitor
    etoposide IV
    6
    PD1 inhibitor
    PD1 inhibitor
    pembrolizumab
    7
    Multi-tyrosine kinase inhibitor
    anlotinib
    8
    PD-L1 inhibitor, CTLA4 inhibitor
    KN046
    9
    EGFR inhibitor
    icotinib
    LV5FU2
    ADOC
    EP
    		10
    Chemotherapy
    CAP
    CaT
    GEM-CAP
    VIP
    CAP
    11
    VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
    sunitinib
    12
    FGFR inhibitor, VEGFR inhibitor, RET inhibitor, c-KIT inhibitor, PDGFR α antagonist
    lenvatinib
    13
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    14
    THF dehydrogenase inhibitor, Thymidylate synthase inhibitor
    pemetrexed
    15
    DNA synthesis inhibitor, Thymidylate synthase inhibitor
    gemcitabine + capecitabine
    16
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    pyrotinib
    17
    pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
    sorafenib
    18
    PDGFR antagonist, mutant c-KIT inhibitor, CSF-1R inhibitor
    avapritinib
    19
    Mesothelin-targeted antibody-drug conjugate, Microtubule inhibitor
    BAY 94-9343
    No biomarker
    KIT mutation
    KIT D820Y
    KIT exon 17 mutation
    EGFR exon 19 deletion
    HER-2 mutation
    PD-L1 overexpression
    PD-L1 expression
    EGFR exon 20 insertion
    HER-2 positive
    SP140 overexpression
    MSLN expression
    EIF4EBP1 expression
    IGF1R expression